行业分析 |
|
|
|
|
全球细胞治疗CMO/CDMO行业发展态势分析 * |
毛开云,赵若春,王跃,范月蕾,江洪波() |
中国科学院上海生命科学信息中心 上海 200031 |
|
Analysis on the Development Trend of CMO/CDMOS Industry in Global Cell Therapy |
MAO Kai-yun,ZHAO Ruo-chun,WANG Yue,FAN Yue-lei,JIANG Hong-bo() |
Shanghai Information Center for Life Sciences, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China |
引用本文:
毛开云,赵若春,王跃,范月蕾,江洪波. 全球细胞治疗CMO/CDMO行业发展态势分析 *[J]. 中国生物工程杂志, 2020, 40(6): 106-112.
MAO Kai-yun,ZHAO Ruo-chun,WANG Yue,FAN Yue-lei,JIANG Hong-bo. Analysis on the Development Trend of CMO/CDMOS Industry in Global Cell Therapy. China Biotechnology, 2020, 40(6): 106-112.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2001027
或
https://manu60.magtech.com.cn/biotech/CN/Y2020/V40/I6/106
|
[1] |
Mohanty R, Chowdhury C R, Arega S , et al. Car t cell therapy: a new era for cancer treatment. Oncology Reports, 2019,42(6):2183-2195.
pmid: 31578576
|
[2] |
Sidana S, Shah N . Car t-cell therapy: is it prime time in myeloma? Blood Advances, 2019,3(21):3473-3480.
doi: 10.1182/bloodadvances.2019000370
pmid: 31714964
|
[3] |
Sato Y, Bando H, Di Piazza M , et al. Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider. Cytotherapy, 2019,21(11):1095-1111.
doi: 10.1016/j.jcyt.2019.10.001
pmid: 31711733
|
[4] |
Lee B, Jung, S, Hashimura, Y . Scale up of allogeneic cell therapy manufacturing in single-use bioreactors: challenges, insights and solutions. Cytotherapy, 2019,21(5):S36-S36.
|
[5] |
Macdonald K N, Ivison S, Hippen K L , et al. Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol. Cytotherapy, 2019,21(12):1216-1233.
|
[6] |
Eaker S, Armant M, Brandwein H , et al. Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing. Stem Cells Translational Medicine, 2013,2(11):871-883.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|